Author

Prajyot R. Sonone

Observed name: Prajyot Sonone

Institutions: Central Drug Research Institute, Academy of Scientific and Innovative Research

Observed institutions: Central Drug Research Institute, National Institute of Pharmaceutical Education and Research, Academy of Scientific and Innovative Research

ORCID: 0009-0002-9463-3927

Observed ORCID: 0009-0002-9463-3927

OpenAlex ID: A5147187481

Ionic Liquids: Structural Properties, Synthetic Approaches, and Characterization

2025 · Aditi Pradhan, Punna Rao Ravi, et al. · ChemistrySelect · 12

Quantitative determination of Lactobacillus acidophilus in combination with Azithromycin, Cefixime, Ofloxacin

2024 · PavanKumar Sathala, Dimple S. Lalchandani, et al. · Microchemical Journal · 4

Human serum albumin-based polymeric nanoparticles for ratiometric co-encapsulation and co-delivery of palbociclib and tamoxifen citrate for synergistic effect in breast cancer management

2026 · Ujala Gupta, Prajyot R. Sonone, et al. · International Journal of Biological Macromolecules · 3

Novel GnRH analogue decorated paclitaxel and CQDs co-loaded theranostic zein nanoparticles for treatment of breast cancer: Formulation optimization, in vitro and in vivo evaluation

2026 · Parth Patel, Pooja Yadav, et al. · International Journal of Biological Macromolecules

Development and Validation of RP–HPLC With Diode‐Array Detection–Based Method for Simultaneous Estimation of Berberine and Bromocriptine: Application in Formulation Development and Pharmacokinetic Studies in Parkinson's Disease

2026 · Keerti Mishra, Amrendra K. Tiwari, et al. · Separation Science Plus

Market potential, postmarketing safety challenges, and treatment cost of CDK4/6 inhibitors

2026 · Srishty Jaiswal, Shourya Tripathi, et al. · Elsevier eBooks

Works count: 7

Citation count: 19

H-index: 3

I10-index: 1